General Archives - Spark Newswire

2 minute read

Industry Groups Back GSK’s Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer

June 20, 2:03 PM

GSK, supported by major industry groups, seeks to stop 70,000 Zantac lawsuits in Delaware, arguing a recent court ruling threatens the state's business-friendly reputation and judicial consistency.

GSK

2 minute read

Johnson & Johnson Faces New Lawsuit(s) Related To Its Talc Products

By Vandana Singh

June 20, 1:53 PM

Johnson & Johnson faces a new class action lawsuit seeking damages and medical monitoring for cancer risk from talc products.

JNJ

2 minute read

German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount

By Vandana Singh

June 20, 1:46 PM

Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.

BMY

1 minute read

Kroger To Gain Traction From Households And Traffic Growth – Analyst Bullish On Future Sales

By Nabaparna Bhattacharya

June 20, 1:35 PM

Kroger Company's strong Q1 earnings beat and growth in digital sales set a positive trajectory amid bullish analyst outlooks on future sales and profitability.

1 minute read

Johnson & Johnson’s Arthritis Drug Shows Potential In Crohn’s Disease

By Vandana Singh

June 20, 1:01 PM

Johnson & Johnson announced that their Phase 3 GRAVITI study of Tremfya (guselkumab) SC therapy for Crohn's disease met all primary and secondary endpoints.

JNJ

2 minute read

HBO’s Dragon Balloon Soars As Warner Bros. Sinks To 52-Week Lows: What It Will Take For Stock To Rebound?

By Surbhi Jain

June 20, 12:58 PM

Warner Bros. Discovery faces decline, with stock at 52-week low. HBO promotes new Game of Thrones prequel with giant dragon balloon on Empire State Bldg.

WBD

2 minute read

What’s Going On With Neurological Disease Focused Trevena On Thursday?

By Vandana Singh

June 20, 12:50 PM

Trevena shares dropped 33.7% to $0.23 with a session volume of 23.65 million. Notably, TRV045 did not cause S1P1R desensitization or protein reduction, unlike fingolimod.

NVS

1 minute read

Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?

By Vandana Singh

June 20, 12:29 PM

Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo.

JAZZ

2 minute read

Plug Power Achieves Certification for One MW Stationary System, Targets Green Hydrogen Expansion

By Nabaparna Bhattacharya

June 20, 12:21 PM

Plug Power achieves certification for its 1 MW stationary system, marking a milestone for green hydrogen expansion amid strategic business priorities and equipment sales focus.

MSFT

1 minute read

Why Is Gilead Sciences Stock Trading Higher On Thursday?

By Vandana Singh

June 20, 12:00 PM

Gilead Sciences announced its Phase 3 PURPOSE 1 trial results showing 100% efficacy of twice-yearly injectable lenacapavir in preventing HIV-1 in cisgender women. The trial met key efficacy endpoints, demonstrating superiority over daily Truvada and background HIV incidence.

GILD